Table 1. Clinical data for the patients included in the study.
| Leprosy classification | Leprosy reactions | ||||||
|---|---|---|---|---|---|---|---|
| WHO* | n (%) | RJ** | n (%) | Neuritis | Type 1 | Type 2 | No reactions |
| PB | 9 (12.3%) | I | 3 (4.1%) | 0 | 0 | 0 | 3 |
| TT | 6 (8.2%) | 3 | 1 | 0 | 2 | ||
| MB | 64 (87.7%) | BT | 21 (28.8%) | 9 | 3 | 0 | 10 |
| BB | 29 (39.7%) | 10 | 8 | 0 | 13 | ||
| BL | 10 (13.7%) | 3 | 6 | 1 | 2 | ||
| LL | 4 (5.5%) | 1 | 0 | 3 | 1 | ||
| Total | 73 | 73 | 42 | 31 | |||
n: number of patients, with percentages in parentheses.
*WHO: Operational classification proposed by the World Health Organization.
** RJ: Modified Ridley-Jopling classification.